Targeting of children in filariasis mass drug administration [8]

Lancet

Volumn 360, Issue 9343, 2002, Pages 1430-

  Rajendran, R ^a   Sunish, I P ^a   Mani, T R ^a   Munirathinam, A ^a   Satyanarayana, K ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIGEN; DIETHYLCARBAMAZINE;

ADOLESCENT; ADULT; ANTIGEN DETECTION; CHILD; CHILDHOOD; CLEARANCE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FILARIA; FILARIASIS; GROUPS BY AGE; HEALTH PROGRAM; HUMAN; HYPOTHESIS; INDIA; LETTER; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0037010434     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11389-4     Document Type: Letter

References (5)

1. Ravindran B. Mass drug administration to treat lymphatic filariasis. Lancet. 359:2002;1948.
2. Witt C., Ottesen E.A. Lymphatic filariasis: an infection of childhood. Trop Med Int Health. 8:2001;582-606.
3. Mani T.R., Rajendran R., Munirathinam A., et al. Efficacy of co-administration of albendazole and diethylcarbamazine on geohelminthiases: a study from South India. Trop Med Int Health. 7:2002;541-548.
4. Noroes J., Dreyer G., Santos A., Mendes V.G., Mendeiros Z., Addiss D. Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Trans R Soc Trop Med Hyg. 91:1997;78-81.
5. Freeman A.R., Lammie P.J., Houston R., et al. A community-based trial for the control of lymphatic filariasis and iodine deficiency using salt fortified with diethylcarbamazine and iodine. Am J Trop Med Hyg. 65:2001;865-871.